Systemic Lupus Erythematosus (DBCOND0027960)

Identifiers

Synonyms
SLE - Systemic Lupus Erythematosus / SLE / Systemic Lupus Erythematosus (SLE) / Systemic lupus erythematosus / Systemic lupus erythematosis / Lupus erythematosus systemic / Systemic lupus erythematosus, unspecified / LE syndrome / Systemic lupus erythematosus (disorder) / Lupus Erythematosus, Systemic / LE systemic / Disseminated lupus erythematosus / Syndrome lupus / Lupus syndrome / Lupus erythematosis disseminated / Syndrome disseminated lupus erythematosis / Systemic lupus erythematosus synd / St Louis encephalitis / Encephalitis, St. Louis / St. Louis encephalitis / Neuroinvasive Saint Louis encephalitis virus infection (disorder) / Saint Louis encephalitis virus infection (disorder) / St. Louis encephalitis virus infection

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Acetylsalicylic acid
A salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events.
Belimumab
A B-lymphocyte stimulator (BLyS)-specific inhibitor used to treat systemic lupus erythematosus and active lupus nephritis as an add-on therapy.
Betamethasone
A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders.
Bupivacaine
A local anesthetic used in a wide variety of superficial and invasive procedures.
Corticotropin
A diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
Cortisone acetate
A steroid hormone used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and endocrine disorders associated with inadequate production of steroid hormones.
Dexamethasone
A glucocorticoid available in various modes of administration that is used for the treatment of various inflammatory conditions, including bronchial asthma, as well as endocrine and rheumatic disorders.
Hydrocortisone
A glucocorticoid used to treat corticosteroid-responsive dermatoses, endocrine disorders, immune conditions, and allergic disorders.
Hydrocortisone succinate
A corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders.
Hydroxychloroquine
An antimalarial medication used to treat uncomplicated cases of malaria and for chemoprophylaxis in specific regions. Also a disease modifying anti-rheumatic drug (DMARD) indicated for treatment of rheumatoid arthritis and lupus erythematosus.
Methotrexate
An antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis.
Methylprednisolone
A corticosteroid used to treat inflammation or immune reactions across a variety of organ systems, endocrine conditions, and neoplastic diseases.
Methylprednisolone hemisuccinate
A water soluble corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders.
Prednisolone
A glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers.
Prednisone
A corticosteroid used to treat inflammation or immune-mediated reactions and to treat endocrine or neoplastic diseases.
Triamcinolone
A glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06189157
MB-CART19.1 in Refractory SLEtreatment1 / 2recruiting
NCT06445127
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)No drug interventionsdiagnosticNot Availablerecruiting
NCT06647069
DR-0201 in Subjects With Autoimmune DiseasesNo drug interventionstreatment1not_yet_recruiting
NCT06570434
Phase 1b/2a in SLE With Budoputugtreatment1 / 2withdrawn
NCT05966480
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusNo drug interventionstreatment2recruiting
NCT06182969
A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.treatment1 / 2recruiting
NCT06613360
A Study of CLN-978, a CD19-directed T Cell Engager, in Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment1not_yet_recruiting
NCT04234633
Effect of Gender on Clinical Presentation of SLE ِAt Assiut University HospitalsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01031797
QT Dispersion in Patients With Systemic Lupus Erythematosus (SLE)No drug interventionsNot AvailableNot Availablecompleted
NCT01207297
Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritistreatment1completed
NCT05161988
Serum IL 26 as a Marker of Disease Activity in SLENo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05342285
Flow Mediated Dilation in Association With HyperuricemiaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00275899
Role of DcR3 in T Cell Activation in SLE and RANo drug interventionsNot AvailableNot Availableunknown_status
NCT04368299
Telemedicine for Follow-up of Systemic Lupus ErythematosusNo drug interventionshealth_services_researchNot Availablecompleted
NCT04806113
COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseasesprevention3completed
NCT05822219
Vaccine Hesitancy in Black/African Americans With Rheumatic DiseasesNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05230316
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLENo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04018222
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to ClinicNo drug interventionsNot AvailableNot Availableunknown_status
NCT04392791
Does Balnotherapy Influence the Qualitiy of Life in SLENo drug interventionssupportive_careNot Availablecompleted
NCT06581029
Evaluating Mental Health Challenges in Juvenile Lupus Erythematosus and Their CaregiversNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04517240
A Study on Protein Losing Enteropathy In Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT00710021
Vitamin D3 in Systemic Lupus Erythematosustreatment2completed
NCT03093402
JBT-101 in Systemic Lupus Erythematosus (SLE)treatment2completed
NCT03155477
Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin DNo drug interventionstreatmentNot Availablecompleted
NCT00364728
Efferocytosis and Genomic Polymorphism in Autoimmune DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT03142711
Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT04037293
Premature Atherosclerosis in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT05479071
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.No drug interventionsNot AvailableNot Availableunknown_status
NCT02240888
Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody ResponseNo drug interventionstreatmentNot Availablecompleted
NCT03240536
Choosing Tests Wisely in RheumatologyNo drug interventionshealth_services_researchNot Availablecompleted
NCT02483624
3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosustreatment1terminated
NCT03144063
Improving the Assessment of SLE Disease ActivityNo drug interventionsNot AvailableNot Availableunknown_status
NCT01761422
Myocardial Inflammation in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05748925
Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patientsprevention4active_not_recruiting
NCT03984227
New Signaling Pathway Targeting Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT01946880
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)treatment2terminated
NCT05470569
Argentinian Prospective Registry of Patients With LupusNo drug interventionsNot AvailableNot Availablerecruiting
NCT05958446
Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant WomenNo drug interventionsNot AvailableNot Availablerecruiting
NCT00152555
Physical Therapy for Systemic Lupus Erythematosus (SLE)No drug interventionstreatmentNot Availableterminated
NCT05352919
A Study to Evaluate the Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adults With Active Systemic Lupus Erythematosustreatment3enrolling_by_invitation
NCT06675422
JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)No drug interventionstreatment1 / 2recruiting
NCT06659068
Efficacy of Seluang Fish Oil (Rasbora Argyrotaenia) and Synbiotics Supplementation on CD4+CD25+ Foxp3+ T-regulator Cells, IL17/IL-10 Ratio, and Disease Activity in Systemic Lupus Erythematosus PatientsNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT06249438
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyNo drug interventionstreatment1recruiting
NCT06653556
A Study of LCAR-AIO in Subjects with Relapsed/Refractory Systemic Lupus ErythematosusNo drug interventionstreatment0not_yet_recruiting
NCT06626945
AZAHAR Study To Describe Anifrolumab in a Real-World SettingNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05411016
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus ErythematosusNo drug interventionstreatment1recruiting
NCT05567198
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by QuestionnairesNo drug interventionsNot AvailableNot Availablerecruiting
NCT05934149
Lupus Landmark Study: A Prospective Registry and BiorepositoryNo drug interventionsNot AvailableNot Availablerecruiting
NCT05988216
Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availablerecruiting
NCT06032923
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2recruiting
NCT06610409
Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease ActivityNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04604990
National Systemic Lupus Erythematosus Prospective Cohort, Saudi ArabiaNo drug interventionsNot AvailableNot Availablerecruiting
NCT04233164
Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosusbasic_science0completed
NCT06335979
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).No drug interventionstreatment1not_yet_recruiting
NCT06420154
The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune DiseasesNo drug interventionstreatment0not_yet_recruiting
NCT06150651
Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.No drug interventionstreatment1recruiting
NCT05747651
3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erythematosus Study Protocol 2No drug interventionsNot AvailableNot Availablerecruiting
NCT05866861
A Study in Participants With Mild-to-moderate Systemic Lupus ErythematosusNo drug interventionstreatment1recruiting
NCT04866615
Posterior Segment Evaluation of Patients With SLE Using OCT and OCTANo drug interventionsNot AvailableNot Availableunknown_status
NCT06234852
Gradual Withdrawal of Low-dose Glucocorticoid in Clinically Quiescent Systemic Lupus Erythematosus.No drug interventionstreatmentNot Availablecompleted
NCT06560775
Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT06294236
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)treatment1recruiting
NCT00637819
Leflunomide in Systemic Lupus Erythematosustreatment2completed
NCT05688696
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosustreatment2recruiting
NCT04461158
CCCR Lupus Patient Navigator ProgramNo drug interventionssupportive_careNot Availablecompleted
NCT02782039
Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)No drug interventionsNot AvailableNot Availableunknown_status
NCT05458622
3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study ProtocolNo drug interventionssupportive_care3recruiting
NCT04645225
Clinical Characteristic and MEFV Gene Mutations in Patient With Juvenile Onest Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT01992666
GENetic & Immunologic Abnomalies in Systemic Lupus ErythematosusNo drug interventionsotherNot Availablecompleted
NCT06548620
A Study of RD06-04 in Patients With Active Autoimmune DiseasesNo drug interventionstreatment0not_yet_recruiting
NCT06314282
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World UseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03030976
A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)treatment1unknown_status
NCT00960362
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)No drug interventionstreatment1completed
NCT06462144
IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory MyopathyNo drug interventionstreatment0recruiting
NCT05724940
Comparison of Clinical and Serological Differences Among Juvenile, Adult, and Late-onset Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04451772
A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease Statetreatment2completed
NCT06010472
An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosustreatment0recruiting
NCT06063668
Autotaxin as Abiomarker in Systemic Lupus Erythematosus PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06144710
SG301-SC Injection Safety Study in Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment1recruiting
NCT06373081
Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT06585514
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2not_yet_recruiting
NCT06056921
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune DiseaseNo drug interventionstreatment1recruiting
NCT02006784
Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)No drug interventionsNot AvailableNot Availablecompleted
NCT05984251
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participantsbasic_science1completed
NCT04726553
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLEtreatment0recruiting
NCT02779153
Acthar SLE (Systemic Lupus Erythematosus)treatment4withdrawn
NCT05859997
Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune DiseasesNo drug interventionstreatmentNot Availablerecruiting
NCT03975361
Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)No drug interventionsbasic_scienceNot Availableunknown_status
NCT04058028
Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)treatment2completed
NCT03626311
Omega-3 Replacement With Krill Oil in Disease Management of SLENo drug interventionssupportive_careNot Availablecompleted
NCT06548607
Clinical Study on Targeted CD19 CAR-T Therapy for Autoimmune DiseasesNo drug interventionstreatment0recruiting
NCT04702256
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMFtreatment3recruiting
NCT05624437
BElimumab corticoSteroids Sparing Treatment in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT02829541
A Phase 1, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic(PK), and Pharmacodynamic(PD) Study of BIIB068 in Healthy Participantstreatment1completed
NCT01072734
Auto-immunity in Lupus Patients After Influenza VaccineNo drug interventionstreatment2completed
NCT05140824
A Study to Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus Erythematosustreatment1terminated
NCT05000216
COVID-19 Booster Vaccine in Autoimmune Disease Non-Respondersprevention2completed
NCT02804763
A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosustreatment2completed
NCT03031925
Detection of Annexin A2 in Systemic Lupus ErythematosusNo drug interventionsbasic_scienceNot Availablecompleted
NCT06038474
Descartes-08 for Patients With Systemic Lupus ErythematosusNo drug interventionstreatment2recruiting
NCT03978520
A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)treatment2completed
NCT03122431
Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseasestreatment4completed
NCT00608127
Study to Evaluate the Safety, Tolerability and Short Term Efficacy of Extracorporeal Specific Immunoadsorption LupusorbTM Columns for the Treatment of Systemic Lupus Erythematosus (SLE) PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT02811094
LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of RelapseNo drug interventionsotherNot Availableterminated
NCT00779194
Prospective Study of Rapamycin for the Treatment of SLEtreatment2completed
NCT03656562
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patientstreatment2active_not_recruiting
NCT01151644
Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesNo drug interventionsprevention4unknown_status
NCT01753401
Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Diseasetreatment4completed
NCT00582881
Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablerecruiting
NCT03492255
CYCLONES - CYClophosphamide LOw Dose and No Extra SteroidtreatmentNot Availableterminated
NCT00001372
Study of Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablerecruiting
NCT00055055
Study of Families With Twins or Siblings Discordant for Rheumatic DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT04976322
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosustreatment3enrolling_by_invitation
NCT05116163
Breaking Implicit Bias Habits: An Individuation Pilot Study In RheumatologyNo drug interventionshealth_services_researchNot Availablecompleted
NCT05155345
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosustreatment1active_not_recruiting
NCT05504187
Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosustreatment2not_yet_recruiting
NCT05617677
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)treatment3recruiting
NCT05620407
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosustreatment3recruiting
NCT05843643
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosustreatment3recruiting
NCT05869955
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseasestreatment1recruiting
NCT05879718
A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.treatment2recruiting
NCT06153095
A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)No drug interventionstreatment1 / 2recruiting
NCT06238531
A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupustreatment1not_yet_recruiting
NCT06673043
Anifrolumab Real-world Treatment Outcomes in Systemic Lupus ErythematosusNot AvailableNot Availablenot_yet_recruiting
NCT06428188
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune DiseasesNo drug interventionstreatment1 / 2recruiting
NCT06465147
REACT-01: Reversing Autoimmunity Through Cell TherapyNo drug interventionstreatment1recruiting
NCT06530849
A Study of GC012F Injection in Subjects With Refractory Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2recruiting
NCT06559163
A Study of Obexelimab in Patients with Systemic Lupus Erythematosustreatment2recruiting
NCT06594068
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Userstreatment4not_yet_recruiting
NCT06657703
Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.No drug interventionstreatment1not_yet_recruiting
NCT06659029
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab UsersNot AvailableNot Availablenot_yet_recruiting
NCT04882878
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosustreatment2active_not_recruiting
NCT04971590
Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus NephritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05637112
A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical PracticeNo drug interventionsNot AvailableNot Availablerecruiting
NCT05638802
A Study of DS-7011a in Patients With Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2active_not_recruiting
NCT05835986
A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosustreatment1recruiting
NCT06161116
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)No drug interventionstreatment2recruiting
NCT06340750
BAFF CAR-T Cells (LMY-920) for Systemic Lupus ErythematosusNo drug interventionstreatment1not_yet_recruiting
NCT06400537
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus ErythematosusNo drug interventionstreatment1recruiting
NCT06652256
Fatigue in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT06641427
Different Aspects and Etiologies of Gastointestinal Bleeding in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06642870
Rare AutoImmune SElf-management Programme DevelopmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT03747159
Synergetic B-cell Immunomodulation in SLE - 2nd Study.treatment3active_not_recruiting
NCT04895696
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)treatment2recruiting
NCT04963296
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosustreatment3active_not_recruiting
NCT05001737
Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLEtreatment3active_not_recruiting
NCT05039840
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosustreatment2recruiting
NCT05289544
Phone-Based Based Walk with Ease Program for Adults with ArthritisNo drug interventionssupportive_careNot Availablecompleted
NCT05648500
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosustreatment3recruiting
NCT05672576
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosustreatment3recruiting
NCT05818254
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRBNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05835310
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participantstreatment3recruiting
NCT05856448
A Study Evaluating the Effects of GLPG3667 Administered As Oral Treatment in Adult Participants with Active Systemic Lupus ErythematosusNo drug interventionstreatment2recruiting
NCT05917288
A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosustreatment1active_not_recruiting
NCT06106893
A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2recruiting
NCT06106906
A Clinical Study of CD19 CAR-T in Active Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2recruiting
NCT06255028
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases (CALiPSO-1)No drug interventionstreatment1recruiting
NCT06350110
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)No drug interventionstreatment1 / 2recruiting
NCT06570798
A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseasestreatment2not_yet_recruiting
NCT01729455
Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) RegistryNot AvailableNot Availableactive_not_recruiting
NCT04179032
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)treatment2active_not_recruiting
NCT05203419
Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)No drug interventionstreatment1terminated
NCT05639114
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)treatment3recruiting
NCT06293365
Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Diseasebasic_science2recruiting
NCT06581198
A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN)No drug interventionstreatment2recruiting
NCT06618573
Safety of Administering Isoniazid to SLE Patients to Prevent TBprevention2 / 3recruiting
NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).treatment3recruiting
NCT06458972
Safety, Efficacy, and Compliance of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)No drug interventionsNot AvailableNot Availablerecruiting
NCT04895241
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosustreatment3recruiting
NCT05306873
Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupustreatment2terminated
NCT05392790
Progressive Resisted Exercise Plus Aerobic Exercise on Osteoporotic Systemic Lupus ErythmatosustreatmentNot Availablecompleted
NCT05430854
Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Studytreatment2terminated
NCT05440422
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVDtreatment2recruiting
NCT05687526
A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosustreatment1recruiting
NCT05693571
Engagement in CHildhood-Onset Systemic LupusNo drug interventionspreventionNot Availablerecruiting
NCT05961267
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory RheumatismNo drug interventionsNot AvailableNot Availablecompleted
NCT06015230
Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLENo drug interventionstreatment1 / 2active_not_recruiting
NCT06121297
RESET-SLE: a Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2recruiting
NCT06188507
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy ParticipantsNo drug interventionstreatment1recruiting
NCT06222853
Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus ErythematosusNo drug interventionstreatment1recruiting
NCT06456567
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)treatment3recruiting
NCT06475742
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosustreatment3enrolling_by_invitation
NCT06544330
Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With Severe, Refractory Systemic Lupus ErythematosusNo drug interventionstreatment1recruiting
NCT06586359
Bone Mineral Density in Patients with Childhood-onset Systemic Lupus Erythematous, in Relation to Disease Clinical CriteriaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosustreatment3not_yet_recruiting
NCT06593041
ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUSNo drug interventionsNot AvailableNot Availablerecruiting
NCT06599658
COVID-19 Booster and IIV Schedule in Immunocompromised HostsNo drug interventionsprevention2not_yet_recruiting
NCT03919643
BAFF and APRIL and RESPONSE TO BELIMUMAB in SLENo drug interventionsNot AvailableNot Availableunknown_status
NCT00774943
A Study of AMG 557 in Adults With Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT00985803
Physical Activity in Patients With Systemic Lupus ErythematosusNo drug interventionstreatment1unknown_status
NCT01534403
Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjectstreatment2completed
NCT03878303
Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)No drug interventionstreatment1unknown_status
NCT05247203
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosustreatment1completed
NCT03171103
Systemic Lupus and Adverse Pregnancy OutcomeNo drug interventionsNot AvailableNot Availableunknown_status
NCT06340490
A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)treatment1not_yet_recruiting
NCT03541564
An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effectstreatment1completed
NCT03616964
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)treatment3completed
NCT00420121
European Society of Cutaneous Lupus Erythematosus (EUSCLE)No drug interventionsNot AvailableNot Availableunknown_status
NCT05132621
The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy.No drug interventionsNot AvailableNot Availableunknown_status
NCT03178721
Regulatory BCells in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT01127321
A Safety and Tolerability Study of MEDI-570 in Systemic Lupus ErythematosusNo drug interventionstreatment1terminated
NCT02953821
Acthar Gel for Active Systemic Lupus Erythematosus (SLE)treatment4completed
NCT01101802
Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE)treatment4completed
NCT01257802
GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseasestreatment3terminated
NCT00522002
CLUE Study: Connective Tissue Disease Leg Ulcer Etiology StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00544102
Insulin Resistance and Atherosclerosis in Women With LupusNo drug interventionsNot AvailableNot Availablecompleted
NCT00731302
Aspirin Resistance in Systemic Lupus Erythematosus (SLE)other1completed
NCT00410384
A Study of Belimumab in Subjects With Systemic Lupus Erythematosustreatment3completed
NCT03941184
Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityNo drug interventionsNot AvailableNot Availablecompleted
NCT02284984
Synergetic B-cell Immodulation in SLEtreatment2completed
NCT00858884
Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus ErythematosusNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00297284
Memory and Attention Problems in Lupus: New Treatment Trial With ModafiniltreatmentNot Availableterminated
NCT05030779
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus ErythematosusNo drug interventionstreatment0unknown_status
NCT01058343
Safety of IFNa Kinoid in Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2completed
NCT00071487
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)treatment2completed
NCT03252587
An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosustreatment2completed
NCT02653287
Lupus Intervention for Fatigue TrialNo drug interventionstreatmentNot Availablerecruiting
NCT00712933
A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057treatment3completed
NCT05506033
Optimization of Glucocorticoid Taper Strategies for SLE-ITPNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT00519454
Estrogen and Gender Biased AutoimmunityNo drug interventionsNot AvailableNot Availableunknown_status
NCT00979654
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositistreatment2completed
NCT00432354
An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosustreatment2 / 3unknown_status
NCT03488654
CMR-Lupus Comprehensive Approach by Cardiovascular Magnetic Resonance TomographyNo drug interventionsNot AvailableNot Availableterminated
NCT00624351
Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Diseasetreatment2completed
NCT03371251
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Caretreatment1 / 2completed
NCT06137053
Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablerecruiting
NCT00493753
Feasibility and Safety of Acupuncture for Systemic LupusNo drug interventionsNot AvailableNot Availablecompleted
NCT04449653
Mobile Study to Measure and Predict Lupus Disease Activity Using Digital SignalsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00430677
Efficacy and Safety Study of Abatacept to Treat Lupus Nephritistreatment2 / 3terminated
NCT01705977
Belimumab Assessment of Safety in SLEtreatment4completed
NCT04335747
COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic DiseasesNo drug interventionsNot AvailableNot Availableterminated
NCT00671047
The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05828147
Anti-CD20 Antibodies for Treatment of SLE-PAHtreatment4recruiting
NCT05381545
Laser Puncture and Program of Lifestyle Modification in Lupus FemalesNo drug interventionstreatmentNot Availableunknown_status
NCT02504645
A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosustreatment3completed
NCT01395745
CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosustreatment3completed
NCT05971498
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00181298
Memantine in Systemic Lupus ErythematosustreatmentNot Availablecompleted
NCT02124798
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an AutoinjectorNo drug interventionsother2completed
NCT02631005
Walk With Ease Program For Patients With Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availablecompleted
NCT00626197
A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)treatment3terminated
NCT02106897
Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 (Litifilimab) in Healthy Volunteers and Participants With Systemic Lupus Erythematosustreatment1completed
NCT03917797
Mesenchymal Stromal Cells (MSC´s) in Renal LupusNo drug interventionstreatment2recruiting
NCT04835883
Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus PatientsNo drug interventionstreatment2recruiting
NCT03161483
A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosustreatment2completed
NCT04776161
Medication Adherence Patterns in Rheumatic Diseases: A Behavioral TrialNo drug interventionshealth_services_researchNot Availablecompleted
NCT00413361
The Reduction of Systemic Lupus Erythematosus Flares :Study PLUSprevention4completed
NCT04893161
A Model About the Response of Belimumab in SLEtreatment4not_yet_recruiting
NCT04530461
Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT02537028
MSC2364447C Phase 1b in Systemic Lupus Erythematosustreatment1completed
NCT00037128
Study of GL701 in Men With Systemic Lupus ErythematosusNo drug interventionstreatment3unknown_status
NCT05087628
PRV-3279-2a Trial in Systemic LupusNo drug interventionstreatment2active_not_recruiting
NCT06413511
A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Moderate to Severe Systemic Lupus ErythematosusNo drug interventionstreatment1recruiting
NCT02066311
Nelfinavir in Systemic Lupus Erythematosustreatment2terminated
NCT05845593
Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)No drug interventionsNot AvailableNot Availablerecruiting
NCT01261793
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)treatment3completed
NCT00588393
FolateScan in Autoimmune DiseaseNo drug interventionsdiagnostic2completed
NCT03396393
Exploratory Study of DHA in Systemic Lupus Erythematosus Patientstreatment2unknown_status
NCT00392093
Effect of Hormone Replacement Therapy on Lupus Activitytreatment4completed
NCT01753193
An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adultstreatment2completed
NCT04275193
The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus ErythematosusNo drug interventionstreatment2 / 3unknown_status
NCT06576271
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participantstreatment1not_yet_recruiting
NCT03937271
Objective Measurement Methods for Autoimmune Disease and Dry Eye SyndromeNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05559671
Safety of the Herpes Zoster Subunit Vaccine in Lupustreatment4recruiting
NCT01449071
Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)treatment1 / 2completed
NCT00723671
Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric LupusNo drug interventionsdiagnosticNot Availablecompleted
NCT00750971
Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)No drug interventionstreatment2unknown_status
NCT02408471
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint ProsthesisNo drug interventionstreatmentNot Availableterminated
NCT00113971
Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)treatment2terminated
NCT02070978
Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)treatment2terminated
NCT06308978
FT819 in Moderate to Severe Active Systemic Lupus Erythematosustreatment1recruiting
NCT03802578
The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00828178
Efficacy of Fish Oil in Lupus Patientstreatment4completed
NCT05799378
Effects of Stopping Hydroxychloroquine in Elderly Lupus Diseasetreatment3recruiting
NCT00119678
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisoneprevention2completed
NCT03802188
Hydroxychloroquine in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablerecruiting
NCT04060888
A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosustreatment3withdrawn
NCT04747288
Objective Measurement With TCM Pattern for AIDDESNo drug interventionsNot AvailableNot Availablerecruiting
NCT02291588
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT05927688
Assessment of Physician Consideration of ePRO's, From Patients With Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic AdjustmentsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05465707
A Study of CM313 Injection in Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2unknown_status
NCT03556007
A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)basic_science1completed
NCT03312907
A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVEtreatment3completed
NCT05899907
Efficacy and Safety of Telitacicept in Early SLEtreatment4recruiting
NCT02428309
Autologous Polyclonal Tregs for LupusNo drug interventionstreatment1terminated
NCT05292456
Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology ClınıcNo drug interventionsNot AvailableNot Availableunknown_status
NCT03937856
Smartphone Mindfulness Meditation for Patients With Rheumatic DiseasesNo drug interventionstreatmentNot Availableterminated
NCT03618056
Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus ErythematosusNo drug interventionsprevention1completed
NCT04433585
A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)treatment2completed
NCT03771885
BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)No drug interventionstreatment1withdrawn
NCT01170585
A Trial of Rosuvastatin in Systemic Lupus Erythematosustreatment2completed
NCT04839315
COVID-19 Vaccination in Rheumatic Disease PatientsNo drug interventionshealth_services_research0terminated
NCT01112215
Enteric-coated Mycophenolate Sodium Versus Azathioprine for the Extra-renal Lupus Manifestationstreatment4completed
NCT04453215
Laser Therapy for Patients With Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availablecompleted
NCT02725515
A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosustreatment2completed
NCT03742037
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosustreatment2completed
NCT04397237
Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in EuropeNo drug interventionsNot AvailableNot Availableunknown_status
NCT00155532
Skin Denervation in Systemic Lupus ErythematosusNo drug interventionsdiagnostic1completed
NCT05900232
Anti KU Antibodies and Its Relationship With Systemic Lupus ErythematosusNo drug interventionsscreeningNot Availablerecruiting
NCT02880852
Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosustreatment1completed
NCT00774852
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritistreatment2completed
NCT01120652
Reducing Depressive Symptoms in Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availablecompleted
NCT06429800
A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants with Systemic Lupus ErythematosusNo drug interventionstreatment1not_yet_recruiting
NCT00997100
Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)basic_science2completed
NCT00976300
Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Studytreatment2completed
NCT00010400
Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody SyndrometreatmentNot Availablecompleted
NCT04345159
Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT03951259
Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusNo drug interventionstreatment2completed
NCT00071175
Lupus Genetics StudiesNo drug interventionsNot AvailableNot Availablecompleted
NCT03189875
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)No drug interventionsNot AvailableNot Availablecompleted
NCT00004375
Ultraviolet Light Therapy for Systemic Lupus ErythematosusNo drug interventionstreatment2unknown_status
NCT01425775
The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE)treatmentNot Availablecompleted
NCT01541670
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus NephritisNo drug interventionstreatment1terminated
NCT06308770
Fatigue in Lupus Intervention Programmes (FLIP)No drug interventionstreatmentNot Availablerecruiting
NCT05115370
Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19No drug interventionsNot AvailableNot Availablecompleted
NCT00982670
A Study of the Metabolic Syndrome in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT02270970
Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacytreatment4unknown_status
NCT01914770
Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76Not AvailableNot Availablecompleted
NCT00069342
Health Beliefs and Health Behaviors Among Minorities With Rheumatic DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT05796206
A Clinical Study of MIL62 in Systemic Lupus ErythematosusNo drug interventionstreatment2 / 3recruiting
NCT00111306
Study of Epratuzumab in Systemic Lupus Erythematosustreatment3terminated
NCT06001606
Immunogenicity, Reactogenicity of Shingrix in SLEtreatment3recruiting
NCT01988506
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesNo drug interventionstreatment2completed
NCT00065806
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)treatment3completed
NCT05765006
CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosustreatment1recruiting
NCT01642706
Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic TreatmentsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05624749
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)treatment3recruiting
NCT00008749
Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT06411249
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)treatment4recruiting
NCT00541749
A Study of rhuMAb IFNalpha in Adults With Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT03159936
Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)treatment0terminated
NCT05666336
Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patientstreatment4recruiting
NCT00005436
Lupus Cohort--Thrombotic Events and Coronary Artery DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT02975336
A Phase II Study of M2951 in SLEtreatment2terminated
NCT01031836
A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.treatment2completed
NCT03393013
A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritistreatment1 / 2completed
NCT02281513
Activity and Nutrition Trial in Lupus to Energize and RenewNo drug interventionspreventionNot Availablecompleted
NCT03030118
Study of Anti-Malarials in Incomplete Lupus Erythematosusprevention2active_not_recruiting
NCT03248518
Lessening the Impact of Fatigue in Inflammatory Rheumatic DiseasesNo drug interventionstreatmentNot Availablecompleted
NCT03942718
Systemic Lupus Erythematosus Exercise ProgramNo drug interventionstreatmentNot Availablecompleted
NCT00025818
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrometreatment3completed
NCT05478018
Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus PatientsNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT03374618
Neutrophil Extracellular Traps in Systemic SclerosisNo drug interventionsbasic_scienceNot Availablecompleted
NCT06347718
CAR-T Cells in Systemic B Cell Mediated Autoimmune DiseaseNo drug interventionstreatment1 / 2recruiting
NCT02554019
Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment2completed
NCT05326841
Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .treatment3completed
NCT00401141
Abnormalities of B Lymphocytes During Systemic LupusNo drug interventionsNot AvailableNot Availablecompleted
NCT01632241
Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)treatment4completed
NCT01863641
The Effect of Calcitriol on Progress and Activity of Lupus Nephritistreatment2unknown_status
NCT03138941
Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific RegionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04532541
Monogenic Lupus in Childhood Onset Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablerecruiting
NCT01164917
Safety Study of AMG 811 in Subjects With Discoid Lupus ErythematosusNo drug interventionstreatment1terminated
NCT05105217
Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00000417
Psychoeducational Approach to Improve Health in LupusNo drug interventionstreatment2completed
NCT02558517
Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupustreatment3unknown_status
NCT05339217
Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosustreatment3recruiting
NCT04361734
The Role of Lipids in Immune Cell Function in SLE PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT06046534
Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.No drug interventionsNot AvailableNot Availablecompleted
NCT03938324
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic ConditionsNo drug interventionssupportive_careNot Availablecompleted
NCT06327724
Belimumab in SLE Synovial Inflammation and Lymph NodesNot AvailableNot Availablerecruiting
NCT06226324
fMRI Study of Early Brain Injury in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablerecruiting
NCT03288324
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupustreatment1 / 2completed
NCT02920424
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosustreatment1withdrawn
NCT00714116
Study Evaluating The SBI-087 In Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT00000416
Prevention of Arthritis-Related Work DisabilityNo drug interventionspreventionNot Availablecompleted
NCT03724916
A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)other1completed
NCT01484496
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)treatment3completed
NCT04184258
Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem CellsNo drug interventionstreatment1 / 2completed
NCT02525835
Tissue Sodium in Autoimmune DiseaseNo drug interventionstreatmentNot Availablewithdrawn
NCT06029335
Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune DiseasesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06394063
Efficacy and Safety of Telitacicept for Prevention of Flares in SLE PatientspreventionNot Availablerecruiting
NCT06119763
AntiDFS70 Lupus NephritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03370263
BENLYSTA® Special Drug Use InvestigationNot AvailableNot Availablerecruiting
NCT01515163
Exercise and Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availableunknown_status
NCT05262686
Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosustreatment3unknown_status
NCT05315739
Vagus Nerve Stimulation for Systemic Lupus ErythematousNo drug interventionstreatmentNot Availableunknown_status
NCT01283139
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosustreatment2completed
NCT03933839
Internet-Based Pain Coping Skills Training for Patients With LupusNo drug interventionstreatmentNot Availablecompleted
NCT04873739
AS-OCT Study of Cornea and Tear Film Parameters in SLE PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00479622
Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosustreatment1terminated
NCT03451422
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosusbasic_science1completed
NCT01597622
BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115treatment3completed
NCT00668330
Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosustreatment4completed
NCT05714930
LUPUS-BEST - Treat-to-target in Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availablerecruiting
NCT04799730
Expression of CXCR4 in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT01892748
Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus.treatmentNot Availablecompleted
NCT03204448
Clinical Performance of BioCLIA Ro60No drug interventionsNot AvailableNot Availablewithdrawn
NCT05929248
Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With Thrombocytopeniatreatment2not_yet_recruiting
NCT05544448
In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory DiseasesNo drug interventionsbasic_scienceNot Availableunknown_status
NCT06339957
Rheumatology Diet StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05433857
Probiotics in Systemic Lupus Erythematosustreatment2recruiting
NCT01741857
Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2unknown_status
NCT03738826
Reducing Disparities in Medication Adherence in SLENo drug interventionshealth_services_researchNot Availablecompleted
NCT00172666
Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)No drug interventionsNot AvailableNot Availableunknown_status
NCT04908865
Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)treatment4active_not_recruiting
NCT04976465
Treatment and Clinical Outcomes Among SLE Patients in PregnancyNo drug interventionstreatment1recruiting
NCT03757065
Cell Surface Marker Expression in Autoimmune DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT01262365
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosustreatment3completed
NCT04833465
Development of a Therapeutic Endpoint in Pediatric Rheumatologic ConditionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00582465
Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT01649765
Pediatric Lupus Trial of Belimumab Plus Background Standard Therapytreatment2active_not_recruiting
NCT05306574
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)treatment3recruiting
NCT00046774
Monoclonal Antibody Treatment for Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT03027674
Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaudtreatment0completed
NCT03459274
Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in RheumatologyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00000420
Safety of Estrogens in Lupus: Birth Control Pillstreatment3completed
NCT00441220
Cyclophosphamide in Lupus NephritisNo drug interventionsNot AvailableNot Availableunknown_status
NCT01276782
Levothyroxine in Pregnant SLE Patientsprevention4withdrawn
NCT00815282
Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune DiseaseNo drug interventionsdiagnostic4completed
NCT05613582
The Effectiveness of Transcranial Direct Current Stimulation as Adjunctive Treatment for Chronic Daily Headache in Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03407482
An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosustreatment2terminated
NCT03165682
Fatigue, Depression, and Cortical Excitability in Systemic LupusNo drug interventionsNot AvailableNot Availableunknown_status
NCT02625831
Anti-ficolin-3 Autoantibodies in Lupus NephritisNo drug interventionsNot AvailableNot Availablecompleted
NCT00987831
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)treatment1 / 2completed
NCT01440231
Atacicept Demonstrating Dose RESponSetreatment2withdrawn
NCT05698173
Systemic Lupus Erythematosus and Accelerated AgingNo drug interventionsotherNot Availablerecruiting
NCT02418273
Denosumab for Glucocorticoid-treated Children With Rheumatic Disorderstreatment1 / 2withdrawn
NCT04951427
PRediction Of Flares In Lupus With autoantibodiEs and ChemokinesNo drug interventionsNot AvailableNot Availableunknown_status
NCT05540327
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)treatment2recruiting
NCT03262727
The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patientstreatment1completed
NCT03656627
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Diseasetreatment1terminated
NCT03979976
Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosusprevention2 / 3completed
NCT00424476
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)treatment3completed
NCT00775476
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteinetreatment2recruiting
NCT01408576
Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosustreatment3completed
NCT01894360
A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjectstreatment1completed
NCT02962960
A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestationstreatment2completed
NCT00512694
Duke Lupus RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT02102594
Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)treatment2terminated
NCT06449794
Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University HospitalNo drug interventionsNot AvailableNot Availablerecruiting
NCT01764594
Safety Study of CDP7657 in Patients With Systemic Lupus ErythematosusNot Available1completed
NCT01240694
A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus ErythematosusNo drug interventionstreatment3terminated
NCT02350491
Study During Pregnancy of Expression of miRNAs in RA or SLENo drug interventionsNot AvailableNot Availablecompleted
NCT05236491
COvid-19 Vaccine Booster in Immunocompromised Rheumatic DiseasesNo drug interventionsprevention2 / 3recruiting
NCT02875691
Effect of Green Tea on Treatment of LupusNo drug interventionssupportive_care2completed
NCT05193591
Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)No drug interventionsNot AvailableNot Availablerecruiting
NCT00513591
Duke Autoimmunity in Pregnancy RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT02041091
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupustreatment3terminated
NCT00583362
A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02treatment2completed
NCT00004662
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosustreatment3completed
NCT02465580
A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosustreatment2unknown_status
NCT05632029
Laser Acupuncture in Egyptian Systemic Lupus Females With Insulin ResistanceNo drug interventionstreatmentNot Availablerecruiting
NCT00866229
Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Leveltreatment4unknown_status
NCT05261529
Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus ErythematosusNo drug interventionssupportive_careNot Availablerecruiting
NCT01438489
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosustreatment2completed
NCT01509989
International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT02535689
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosusother1completed
NCT05347992
ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05203692
A Study of a Single Ascending Dose Study of DS-7011a in Healthy SubjectsNo drug interventionstreatment1completed
NCT00556192
Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosustreatment2completed
NCT01597492
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)treatment4completed
NCT00504244
Myfortic Versus Azathioprine in Systemic Lupus Erythematosustreatment3terminated
NCT02530944
Web-based Genetic Research on LupusNo drug interventionsNot AvailableNot Availablecompleted
NCT02655640
The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic SclerosisNo drug interventionsNot AvailableNot Availablecompleted
NCT06356740
Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosustreatment2not_yet_recruiting
NCT00732940
Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)treatment2terminated
NCT05007340
ILD-SARDs Registry and BiorepositoryNo drug interventionsNot AvailableNot Availablerecruiting
NCT02618967
Single Ascending Dose Study of AMG 570 in Healthy Subjectstreatment1completed
NCT04294667
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosustreatment3completed
NCT00371501
Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosusprevention4completed
NCT04276701
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular DiseasesNo drug interventionsotherNot Availablerecruiting
NCT00089804
Study of LJP 394 in Lupus Patients With History of Renal Diseasetreatment3terminated
NCT00293072
Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitistreatment2completed
NCT01616472
WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)No drug interventionsNot AvailableNot Availablecompleted
NCT04046172
Treatment of Periodontal Disease in Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availableunknown_status
NCT03527472
Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosustreatment2recruiting
NCT06041568
A Study of Imvotamab in Severe Systemic Lupus Erythematosustreatment1recruiting
NCT06518668
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosustreatment1recruiting
NCT06462768
Neutrophil Extracellular Traps in Different Forms of Systemic SclerosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02456168
Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT00198068
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)No drug interventionsNot AvailableNot Availablerecruiting
NCT05607368
Mast Cells Are Involved in the Mechanism of NPSLE EpilepsyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02219269
A Complex Contraception RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT00137969
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosustreatment2 / 3completed
NCT01305746
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321No drug interventionstreatment2completed
NCT01230112
The Role of ITGAM in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT01716312
Omalizumab for Lupustreatment1completed
NCT06535412
A Study of IMC-002 for the Treatment of Active Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2not_yet_recruiting
NCT03142412
Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment OptimizationNo drug interventionsNot AvailableNot Availableunknown_status
NCT01741012
Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patientsprevention1completed
NCT02270710
Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune DiseaseNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03063281
Anti-ficolin-2 Autoantibodies in Lupus NephritisNo drug interventionsNot AvailableNot Availablecompleted
NCT00660881
Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Diseasetreatment2completed
NCT01162681
PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment2completed
NCT03296995
Accuracy, Feasibility and Acceptance of CGM LupusNo drug interventionsscreeningNot Availableunknown_status
NCT00342095
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02472795
Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosustreatment1 / 2completed
NCT02708095
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)treatment2completed
NCT04356014
Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT04942314
Practice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02842814
Prediction of Relapse Risk in Stable Systemic Lupus ErythematosustreatmentNot Availablecompleted
NCT02922114
Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT00383214
Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)treatment3terminated
NCT05418855
Clinical Characteristics and Outcomes of SLE Patients Admitted to Critical Care UnitNo drug interventionsNot AvailableNot Availableunknown_status
NCT00006055
Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasestreatmentNot Availableunknown_status
NCT03734055
Peer Approaches to Lupus Self-managementNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT01520155
CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)No drug interventionsNot AvailableNot Availablecompleted
NCT02330250
Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus TreatmentNo drug interventionssupportive_careNot Availablecompleted
NCT03276923
Maternal Autoimmune Disease Research Alliance (MADRA) RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT01322308
Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosustreatment4completed
NCT00011908
Humanized LL2IGG to Treat Systemic Lupus Erythematosustreatment1completed
NCT06297408
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosustreatment1not_yet_recruiting
NCT01488708
On Open-Label Study in Participants With Systemic Lupus Erythematosustreatment3terminated
NCT04580108
Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT03687138
Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic TechniquesNo drug interventionsNot AvailableNot Availablecompleted
NCT02084238
Low-dose IL-2( Interleukin-2) Treatment in SLEtreatmentNot Availablecompleted
NCT01205438
A Study of LY2127399 in Participants With Systemic Lupus Erythematosustreatment3completed
NCT03735238
Implementing the Decision-Aid for Lupus (IDEAL Strategy)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01018238
An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)No drug interventionstreatment1withdrawn
NCT05253638
Evaluation Of Serum MIF Level in SLE PatientsNo drug interventionsdiagnosticNot Availableunknown_status
NCT03933943
A Study of LY3361237 in Participants With Systemic Lupus Erythematosusbasic_science1completed
NCT06349343
CD19/BCMA HLA-independent TCR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus ErythematosusNo drug interventionstreatment1not_yet_recruiting
NCT01176643
Development and Evaluation of Modified Yoga in Systemic Lupus Erythematosus (SLE)No drug interventionssupportive_careNot Availablecompleted
NCT06255743
(Anti-Ribosomal P Protein,Anti-U1 RNP, Anti-Nucleosome and Anti-ds DNA Antibodies) and Relation to Depression and Anxiety in SLENo drug interventionsdiagnosticNot Availablerecruiting
NCT03103243
Pilot Study to Investigate Contemplative Intervention in Lupus PatientsNo drug interventionstreatmentNot Availablecompleted
NCT02307643
Exploratory Study of MT-1303 in Systemic Lupus Erythematosus PatientsNo drug interventionstreatment1completed
NCT06151990
Assessment of Lipid Profile in Juvenile Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablerecruiting
NCT01559090
Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus.treatment2completed
NCT00278590
Allogeneic Stem Cell Transplantation in Systemic Lupus ErythematosusNo drug interventionstreatment1withdrawn
NCT04213690
A Pilot Study to Explore the Role of Gut Flora in LupusNo drug interventionsNot AvailableNot Availableunknown_status
NCT05590390
Osteoporosis and Fragility Fractures Among SLE Patients. (FRAIL Trial)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02437890
A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosustreatment2completed
NCT00368264
TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )treatment2 / 3terminated
NCT02665364
Phase IIb Study of IFN-K in Systemic Lupus ErythematosusNo drug interventionstreatment2terminated
NCT03684564
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrometreatment2active_not_recruiting
NCT04239521
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNo drug interventionsNot AvailableNot Availablecompleted
NCT00911521
Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Studyprevention4completed
NCT00000421
Serologically Active, Clinically Stable Systemic Lupus Erythematosustreatment2completed
NCT05880121
Neuron-specific Humoral and Cellular Immune Correlates of Structural and Functional Brain Connectomics in Neuropsychiatric LupusNo drug interventionsNot AvailableNot Availablerecruiting
NCT04358302
Individual Patient Exposure and Response in Pediatric LupusNo drug interventionssupportive_careNot Availablecompleted
NCT05426902
Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)No drug interventionshealth_services_researchNot Availablecompleted
NCT04355702
Covid-19 in Lupus PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04077684
Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trialtreatment2recruiting
NCT04110184
Haematological Indices in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT04983784
The Effectiveness of Walking in Patients With Systemic Lupus ErythematosusNo drug interventionshealth_services_researchNot Availableunknown_status
NCT03254784
A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulationtreatment1completed
NCT01549184
Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune ThrombocytopeniaNo drug interventionsNot AvailableNot Availablecompleted
NCT04956484
Belimumab In Early Systemic Lupus Erythematosustreatment4completed
NCT05430087
Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus Patientstreatment2completed
NCT00418587
Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)treatment1completed
NCT00120887
Lupus Atherosclerosis Prevention Studyprevention4completed
NCT00006133
Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus ErythematosustreatmentNot Availablecompleted
NCT04810754
An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosustreatment2unknown_status
NCT01697254
The CARRA RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT02477254
Long-term Immunogenicity of a HPV Vaccine in SLENo drug interventionsNot AvailableNot Availablecompleted
NCT02925351
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory DiseasesNo drug interventionsdiagnostic0completed
NCT04857151
Stress, Inflammation and Immune Response Pilot Study- Aim 3No drug interventionsbasic_science0completed
NCT01852851
Employment and Arthritis: Making it WorkNo drug interventionssupportive_careNot Availableunknown_status
NCT00203151
A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupustreatment2terminated
NCT03427151
Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosustreatment3completed
NCT03334851
Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid ArthritisNo drug interventionsbasic_science1completed
NCT00392951
Sirolimus for Autoimmune Disease of Blood Cellstreatment1 / 2completed
NCT03583853
Autophagy in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT05704153
Modelling and Control of Non-invasive Vagus Nerve Stimulation for Autoimmune Diseases (1A)No drug interventionsscreeningNot Availablerecruiting
NCT04736953
Sirolimus Treatment Of Patients With SLEtreatment2not_yet_recruiting
NCT04447053
Sequential Belimumab and T-cell Based Therapy in SLEbasic_science4recruiting
NCT01345253
GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asiatreatment3completed
NCT05451277
At the Heart of the Matter - Speckle Tracking Echocardiography in Lupus Mothers and Their OffspringNo drug interventionsNot AvailableNot Availableunknown_status
NCT00849745
Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune DiseasesNo drug interventionstreatment1terminated
NCT06361745
Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesNo drug interventionstreatmentNot Availablerecruiting
NCT04136145
Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjectstreatment1completed
NCT03816345
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancertreatment1recruiting
NCT00508898
The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuriatreatment4withdrawn
NCT05001698
Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE)treatment1completed
NCT02847598
Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)treatment2completed
NCT06417398
Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesNo drug interventionstreatment0not_yet_recruiting
NCT00610805
Cardiology Prevention in Systemic Lupus Erythematosus (SLE)No drug interventionspreventionNot Availablewithdrawn
NCT03746197
Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus ErythematosusNo drug interventionssupportive_careNot Availableunknown_status
NCT04305197
A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)treatment1 / 2completed
NCT06333483
A Study of CD19 Targeted CAR T Cell Therapy in Patients With Severe, Refractory Systemic Lupus Erythematosus (SLE)treatment1recruiting
NCT06294483
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.No drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02349061
A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosustreatment2completed
NCT03953261
Effect of Curcumin on Systemic Lupus Erythematosustreatment2terminated
NCT02988661
Women Empowered to Live With Lupus StudyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03746028
The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus PregnanciesNo drug interventionsNot AvailableNot Availableunknown_status
NCT04180228
Human Papilloma Virus Vaccination and Chronic Inflammatory Rheumatic Diseases.No drug interventionsNot AvailableNot Availablecompleted
NCT05516511
Serum Levels of Angiotensin Converting Enzyme in Systemic Lupus Erythematous PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01781611
Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)treatmentNot Availableterminated
NCT01093911
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)Not Available1completed
NCT00082511
GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoidstreatment3completed
NCT00611611
BLYS and IFN in SLENot AvailableNot Availablecompleted
NCT04186871
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritistreatment2completed
NCT02037971
Aerobic Exercise on Improving Sleep in Systemic Lupus Erythematosus.No drug interventionshealth_services_researchNot Availableunknown_status
NCT06056778
The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients With Reproductive Issues (PRISMA)No drug interventionsNot AvailableNot Availablecompleted
NCT00235378
Genetic Study of Lupus Patients and Their FamiliesNo drug interventionsNot AvailableNot Availablecompleted
NCT00005778
High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV CyclophosphamideNo drug interventionstreatment3completed
NCT00747578
Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in TaiwanNo drug interventionsNot AvailableNot Availableunknown_status
NCT01956188
Omega 3 in LES and APSNo drug interventionssupportive_careNot Availableunknown_status
NCT00188188
Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart DiseaseNo drug interventionstreatment4unknown_status
NCT04397107
The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic DiseasestreatmentNot Availablecompleted
NCT04902807
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and InflammationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05659407
BAFF-var as a Biomarker of Response to B-depletive Treatment in Systemic Lupus Erythematosus and Rheumatoid ArthritisNot AvailableNot Availablerecruiting
NCT00657007
Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)treatment1completed
NCT00125307
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritistreatment4completed
NCT04411407
PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLENo drug interventionsotherNot Availablecompleted
NCT02151409
Dose-escalation Trial of Anti-C5aR Antibody in Healthy SubjectsNo drug interventionstreatment1completed
NCT02321709
Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female PatientsNo drug interventionsbasic_science1completed
NCT01840709
Effectiveness Study of Psychotherapy in Systemic Lupus ErythematosusNo drug interventionshealth_services_researchNot Availableunknown_status
NCT01687309
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and GenderNo drug interventionstreatment1completed
NCT00786409
Immunogenicity and Safety of HPV Vaccine Gardasil in Young WomenpreventionNot Availablecompleted
NCT03575156
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic SclerosisNo drug interventionsotherNot Availablecompleted
NCT00004756
Study of Individualized Instruction Versus Pamphlet in Systemic Lupus ErythematosusNo drug interventionseducational_counseling_trainingNot Availablecompleted
NCT01777256
An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184No drug interventionstreatment2terminated
NCT02119156
Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patientstreatment3completed
NCT01923415
A Non-drug Study Profiling Cutaneous LupusNo drug interventionsNot AvailableNot Availablecompleted
NCT02955615
ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)treatment2completed
NCT02403115
Prediction of Outcome of Lupus NephritisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02932137
Anti-infection of Low-does IL-2 in SLEpreventionNot Availablecompleted
NCT00382837
Study of Epratuzumab in Systemic Lupus Erythematosustreatment3withdrawn
NCT00280137
Health-related Quality of Life Measure in Pediatric LupusNo drug interventionsNot AvailableNot Availablecompleted
NCT00594932
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritistreatment1 / 2completed
NCT00962832
A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosustreatment2completed
NCT01327352
Evaluation of the Influence of Food Regimen on Oshadi D AbsorptionNo drug interventionsNot AvailableNot Availablecompleted
NCT00076752
Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosustreatment2completed
NCT03915652
Addressing Disparities in Lupus Care Through an Integrated Care Management ProgramNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT05358652
Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal BiopsyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02908100
A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosustreatment2completed
NCT02194400
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT06227559
The Role of Some Hematological Parameters in Juvenile Systemic Lupue ErythematosusNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02391259
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT03206359
GADD34 and Type I IFN Response Genes in SLENo drug interventionsNot AvailableNot Availablecompleted
NCT04648059
Epigenetics in Lupus NephritisNo drug interventionsNot AvailableNot Availableunknown_status
NCT01135459
A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)No drug interventionstreatment2completed
NCT06365359
Systemic Lupus Erythematosus and Chlordecone Impregnation in MartiniqueNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06458075
Intervention to Improve Communication and Medication Adherence in LupusNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05243875
Lupus Education Alliance ProgramNo drug interventionshealth_services_researchNot Availablerecruiting
NCT01837875
Intervention to Improve Quality of Life in African American Lupus PatientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT02422875
Comparative Autoantibody and Immunologic Cell Marker StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04749875
Study of Leukocyte Populations in Patients With Chronic InflammatoryNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02732470
Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)No drug interventionspreventionNot Availablecompleted
NCT02533570
Dose Ranging Study of Brentuximab Vedotin in Adults With Lupustreatment2terminated
NCT05636670
Assessment of Cognitive Function and Gut Microbiota Analysis in Real World Patients With Lupus Cerebrovascular DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03107442
Exercise and Arterial Stiffness in Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availablecompleted
NCT05748899
Effect of Applying Ujjayi Pranayama on Cortisol in Lupus PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT02338999
Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)prevention1 / 2completed
NCT00752999
Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosustreatment2withdrawn
NCT05791799
Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosusprevention2 / 3not_yet_recruiting
NCT06166199
Effects of High-intensity Interval Training in Patients With Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availablerecruiting
NCT04570306
Transcriptional and Immune Parameters of Response to BelimumabNot AvailableNot Availablecompleted
NCT02443506
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT04671706
Belimumab in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01475149
Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)No drug interventionsNot AvailableNot Availablecompleted
NCT05029336
Autologous Stem Cell Transplant (ASCT) for Autoimmune DiseasesNo drug interventionstreatment2recruiting
NCT01381536
Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)No drug interventionstreatment1completed
NCT02411136
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT04582136
Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosustreatment2recruiting
NCT06378736
Electroencephalogram Recording in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablerecruiting
NCT02711813
TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatmenttreatment2terminated
NCT00483613
Effects of Treatment of Chronic Stress in Patients With LupusNo drug interventionssupportive_careNot Availablecompleted
NCT00383513
Study of Epratuzumab in Systemic Lupus Erythematosustreatment2completed
NCT06479213
REACH (Restore Energy, Activity Can Help) Lupus StudyNo drug interventionshealth_services_researchNot Availablerecruiting
NCT02021513
Pilot Study - Effect of Omega-3 on Systemic Lupus ErythematosusNo drug interventionstreatment2completed
NCT06073613
Periodontal Status in Patients With Chronic Skin DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT04486118
Centrally Acting ACE Inhibition in SLEtreatment2recruiting
NCT05179018
Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT00000419
Safety of Estrogens in Lupus: Hormone Replacement Therapytreatment3terminated
NCT04515719
Efficacy and Safety of Belimumab in SLE Patientsprevention4unknown_status
NCT05879419
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseasesprevention4recruiting
NCT04835441
ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosustreatment2active_not_recruiting
NCT00017641
Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosustreatment1unknown_status
NCT00325741
Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus ErythematosusNo drug interventionstreatment1terminated
NCT05798117
An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus ErythematosusNo drug interventionstreatment1 / 2recruiting
NCT05631717
The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LNtreatment3recruiting
NCT05045417
IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ DamageNo drug interventionsNot AvailableNot Availableunknown_status
NCT03845517
A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)treatment2completed
NCT03189017
A Phase I Study of ICP-022 in Healthy SubjectsNo drug interventionstreatment1completed
NCT05157334
The Effect of Deep Breathing and Transcutaneus Electrical Nerve Stimulation on Heart Rate VariabilityNo drug interventionsbasic_scienceNot Availableunknown_status
NCT00271934
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II StudyNo drug interventionstreatment2completed
NCT00006134
Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus NurtureNo drug interventionsNot AvailableNot Availablecompleted
NCT04925934
Study of VIB7734 for the Treatment of Moderate to Severely Active SLEtreatment2completed
NCT03817424
A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositistreatment1completed
NCT00391924
Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrometreatment2completed
NCT00189124
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Preventiontreatment2 / 3completed
NCT03952624
Patient-Centered Assessment of Symptoms and OutcomesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04082416
Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)No drug interventionstreatment3completed
NCT06549296
Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune DiseasesNo drug interventionstreatment0not_yet_recruiting
NCT01405196
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosustreatment2completed
NCT02450396
Pregnancy and Medically Assisted Conception in Rare DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04751396
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04032496
Contemplation-Based Intervention and Health Outcomes RCT in Lupus PatientsNo drug interventionsbasic_scienceNot Availableunknown_status
NCT00010335
Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune DisordersNo drug interventionstreatment1completed
NCT00230035
Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)treatment2withdrawn
NCT01953835
A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184treatment1completed
NCT03312335
Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosusbasic_science2completed
NCT00611663
Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus ErythematosusNo drug interventionstreatment2 / 3completed
NCT00004663
Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT00519363
Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptorstreatment1 / 2completed
NCT05278663
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus ParticipantsNo drug interventionstreatment1 / 2completed
NCT02633163
Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)treatment2recruiting
NCT04402086
Rheumatology Patient Registry and BiorepositoryNo drug interventionsNot AvailableNot Availablerecruiting
NCT05123586
A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosustreatment2terminated
NCT03125486
Compassionate Use for Subcutaneous (SC) BelimumabNot AvailableNot Availableno_longer_available
NCT05162586
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)treatment2active_not_recruiting
NCT06411639
Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseasestreatment1not_yet_recruiting
NCT03543839
Trial of Belimumab in Early Lupustreatment4recruiting
NCT03446339
Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE)No drug interventionsNot AvailableNot Availableunknown_status
NCT06228222
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00470522
Study of Methotrexate in Lupus Erythematosustreatment3completed
NCT03517722
A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosustreatment3terminated
NCT05379725
Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in LupusNo drug interventionsotherNot Availableactive_not_recruiting
NCT02319525
Individualized Patient Decision Making for Treatment Choices Among Minorities With LupusNo drug interventionssupportive_careNot Availablecompleted
NCT05763225
Validation of Patient E-tool to Measure Systemic Lupus ActivityNo drug interventionsNot AvailableNot Availablecompleted
NCT03843125
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)treatment3terminated
NCT01689025
An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)treatment1terminated
NCT00417430
Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studiestreatment2completed
NCT00818948
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without GlomerulonephritisNo drug interventionstreatment1completed
NCT03200548
Acupressure for Fatigue in Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availableterminated
NCT02270957
Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approachestreatment2completed
NCT04750057
Anifrolumab Early Access ProgramNot AvailableNot Availableno_longer_available
NCT02320357
Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematoustreatment1 / 2completed
NCT05328557
A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy VolunteersNo drug interventionstreatment1active_not_recruiting
NCT00188357
HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus ErythematosusNo drug interventionspreventionNot Availableunknown_status
NCT01359826
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patientstreatment4withdrawn
NCT03949426
Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy SubjectsNo drug interventionstreatment1completed
NCT01269866
Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus ErythematosustreatmentNot Availablecompleted
NCT04440566
O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus ErythematosusNo drug interventionsotherNot Availablecompleted
NCT00004665
Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosustreatment2completed
NCT02917265
Transcutaneous Vagus Nerve Stimulation for the Treatment of LupusNo drug interventionstreatment2terminated
NCT03348774
Scrutinizing the Heterogeneity of SLE: Defining PhenotypesNo drug interventionsNot AvailableNot Availableunknown_status
NCT02554474
OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory ArthritisNo drug interventionssupportive_careNot Availablecompleted
NCT01709474
Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosustreatment2terminated
NCT01474720
Zostavax in Systemic Lupus Erythematosusprevention1completed
NCT02074020
CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritistreatment3withdrawn
NCT05967520
JMKX000189 for Moderate to Severe Active Systemic Lupus ErythematosusNo drug interventionstreatment2recruiting
NCT00563082
Analyzing the Association of Gene Variants With Increased Risk of Coronary Heart Disease in Women With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT04786431
Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT05329831
Effects of Telehealth Initiative on Lupus PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT03896373
Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of LupusNo drug interventionsNot AvailableNot Availablecompleted
NCT02799173
Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular CalcificationNo drug interventionsbasic_scienceNot Availablecompleted
NCT06448273
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult SubjectsNo drug interventionstreatment1recruiting
NCT00074373
The Research Registry for Neonatal LupusNo drug interventionsNot AvailableNot Availablecompleted
NCT05424627
Myeloid Derived Suppressor Cells in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00001676
Cyclophosphamide and Fludarabine to Treat Lupus Nephritistreatment1completed
NCT06316076
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseasestreatment1recruiting
NCT00527176
Pulse Corticosteroid Therapy and Effect on Brain Water DiffusivityNo drug interventionsNot AvailableNot Availableunknown_status
NCT03042260
Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematousprevention4unknown_status
NCT02741960
The Effect of Metformin on Reducing Lupus Flarestreatment4completed
NCT04266860
Establishing Clinical Utility of a New Diagnostic Test for Rheumatology PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT03186794
Aerobic Exercise in Women With Systemic Lupus ErythematosusNo drug interventionssupportive_careNot Availableterminated
NCT01838694
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.No drug interventionstreatment1 / 2completed
NCT00390091
Study of LJP 394 (Abetimus Sodium) in Lupus Patientsdiagnostic2withdrawn
NCT06373991
A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosustreatment1not_yet_recruiting
NCT04877691
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosustreatment3recruiting
NCT05859191
Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic LupusNo drug interventionsNot AvailableNot Availablerecruiting
NCT01196091
A Study of LY2127399 in Participants With Systemic Lupus Erythematosustreatment3completed
NCT06316791
Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseasestreatment0recruiting
NCT00036491
Anti-CD20 in Systemic Lupus Erythematosustreatment1 / 2completed
NCT06581562
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.treatment1recruiting
NCT02741362
Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's SyndromeNo drug interventionstreatment1terminated
NCT01351662
Balancing Lupus Experiences With Stress StrategiesNo drug interventionshealth_services_research1 / 2completed
NCT06567080
JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune DiseasesNo drug interventionstreatment1not_yet_recruiting
NCT01460680
Membrane Polyunsaturated Fatty Acid Content in Fibromyalgia and Systemic Lupus Erythematosus (SLE)No drug interventionsNot AvailableNot Availableunknown_status
NCT02453880
Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic IllnessNo drug interventionspreventionNot Availablecompleted
NCT01582880
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesistreatment1 / 2completed
NCT00094380
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)treatment1 / 2completed
NCT05689580
The Influence of Ketogenic Diet on Lupus Nephritis Patients' ImmunityNo drug interventionstreatmentNot Availableunknown_status
NCT04320680
Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary ConsultationNo drug interventionsdiagnosticNot Availablerecruiting
NCT00976729
NOX-E36 First-in-Human (FIH) StudyNo drug interventionstreatment1completed
NCT03480529
Monitoring the IMmUological TOXicity of DrugsNo drug interventionsNot AvailableNot Availablecompleted
NCT01712529
Physical Exercise, Endothelial Function and Progenitor Endothelial Cells in Systemic Lupus Erythematosus PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT02306629
Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Bloodtreatment1completed
NCT00657189
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupustreatment2completed
NCT05863689
Microvascular Ocular Changes of Systemic Lupus ErythematousNo drug interventionsNot AvailableNot Availablerecruiting
NCT05090189
Exercise and Nutrition Recommendations for Patients Using Glucocorticoids (ENRG)No drug interventionstreatmentNot Availableunknown_status
NCT02822989
Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal PainNo drug interventionstreatmentNot Availableunknown_status
NCT02609789
A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT06551389
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRUNo drug interventionsNot AvailableNot Availablerecruiting
NCT02162992
Systemic Lupus Erythematous and Heart Conduction DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT01687192
Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.other2completed
NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT02660944
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)No drug interventionstreatment2completed
NCT02034344
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy VolunteersNo drug interventionsNot AvailableNot Availablecompleted
NCT04400240
Care Coordination Approaches to Learning Lupus Self-managementNo drug interventionspreventionNot Availablecompleted
NCT02185040
A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.treatment2completed
NCT01702740
A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus ErythematosusNo drug interventionstreatment1completed
NCT03504540
Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal "Pseudo-drusen-like" Deposits: Case-control Study (PL-AMD)No drug interventionsNot AvailableNot Availablecompleted
NCT01845740
Phase Ib Study of SC Milatuzumab in SLEtreatment1completed
NCT03920267
Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosustreatment2active_not_recruiting
NCT00724867
A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United Statestreatment3completed
NCT02514967
CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritistreatment3terminated
NCT04700267
A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus ErythematosusNo drug interventionstreatment1terminated
NCT04961567
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosustreatment3recruiting
NCT04431167
Healthy Lifestyle Intervention in Patients With Systemic Lupus Erythematosus: The Living Well With Lupus StudyNo drug interventionstreatmentNot Availableunknown_status
NCT01471301
Ultrasound Evaluation of Hands in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT01076101
Autoimmunity in Sisters of Lupus PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06421701
Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosustreatment1recruiting
NCT05141201
SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05539001
Screening Biomarkers for Severe Lupus Based on Multi-omics StudiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03219801
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus ErythematosusNo drug interventionstreatment0unknown_status
NCT01157468
Catalytic Antibodies and Lupus in MartiniqueNo drug interventionsNot AvailableNot Availablecompleted
NCT01972568
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosustreatment2completed
NCT06360068
A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosustreatment2not_yet_recruiting
NCT01330368
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT00756769
Systemic Lupus Erythematosus in Gullah HealthNo drug interventionsNot AvailableNot Availablerecruiting
NCT01911169
Vitamin D to Improve Endothelial Function in SLEprevention2completed
NCT02756546
Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosisdiagnostic1 / 2completed
NCT04141046
LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLENo drug interventionsbasic_scienceNot Availableterminated
NCT03179046
Cardiac and Laboratory Findings in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT06379646
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT03473912
Meir Medical Center Rheumatologic BiobankNo drug interventionsNot AvailableNot Availablerecruiting
NCT05362812
Prediction of Lupus Renal Flares StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00001212
Drug Therapy in Lupus Nephropathytreatment2completed
NCT03616912
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosustreatment3terminated
NCT02801812
Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT01532310
Belimumab (BENLYSTA®) Pregnancy RegistryNot AvailableNot Availablecompleted
NCT02331810
Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female PatientsNo drug interventionsbasic_science1withdrawn
NCT02885610
Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)No drug interventionstreatment2completed
NCT01060410
Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus TreatmentNot AvailableNot Availablecompleted
NCT00381810
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosustreatment3terminated
NCT04293510
Evaluation of Janus Kinase_3 in Juvenile Onset Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableunknown_status
NCT05057481
Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosustreatment3unknown_status
NCT05916781
Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosustreatment4recruiting
NCT05287581
Motivating Individuals With Lupus to ExerciseNo drug interventionssupportive_careNot Availablecompleted
NCT02769195
Utility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLENo drug interventionsNot AvailableNot Availablecompleted
NCT00004795
Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosustreatment2 / 3completed
NCT02524795
Omega 3 Fatty Acids and Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availablecompleted
NCT00124514
Triptorelin for Ovary Protection in Childhood Onset Lupusdiagnostic2completed
NCT02950714
Dissemination of the Lupus Interactive NavigatorNo drug interventionsotherNot Availablecompleted
NCT04558814
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ DamageNo drug interventionsdiagnosticNot Availableunknown_status
NCT05146414
Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT00684255
Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)treatment1terminated
NCT04098055
Effect of Insoles in Patients With Systemic Lupus ErythematosusNo drug interventionsotherNot Availablecompleted
NCT05260255
Effect of Vitamin D Supplement on Disease Activity in SLEtreatmentNot Availableunknown_status
NCT04022655
Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care UnitNo drug interventionsNot AvailableNot Availableunknown_status
NCT01597050
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) LesionsNo drug interventionstreatment2completed
NCT01689350
A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus TreatmentNo drug interventionssupportive_careNot Availablecompleted
NCT02477150
Safety and Immunogenicity of a Zoster Vaccine in SLEprevention4completed
NCT01516450
Japanese phase1 Study of Belimumab (IV vs SC)No drug interventionsbasic_science1completed
NCT00739050
Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)treatment4terminated
NCT06404723
The Predictive and Prognostic Values of the Fibrinogen to Albumin Ratio and C-reactive Protien to Albumin Ratio in Systemic Lupus Erythematosus PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03804723
Glucocorticoids Withdrawal in Early Systemic Lupus ErythematosustreatmentNot Availableunknown_status
NCT03098823
A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLEtreatment4completed
NCT06087523
Pulmonary Disease Among Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00042523
Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus ErythematosusNo drug interventionsNot AvailableNot Availablecompleted
NCT04647708
Study of M5049 in CLE and SLE Participantstreatment1completed
NCT00035308
Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Diseasetreatment3completed
NCT02364908
Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic LupusNo drug interventionspreventionNot Availablecompleted
NCT04516408
Recombinant Zoster Vaccine in Stable SLE PatientstreatmentNot Availablerecruiting
NCT05048238
Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupustreatment1completed
NCT00539838
A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)treatment3terminated
NCT00624338
Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)treatment2 / 3completed
NCT00054938
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)treatment2completed
NCT01702038
Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLEtreatment2withdrawn
NCT00278538
Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus ErythematosusNo drug interventionstreatment2completed
NCT03537638
Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLENo drug interventionshealth_services_researchNot Availablecompleted
NCT04335643
Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus ErythematosusNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00004643
Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosustreatment2completed
NCT03187743
Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With PrednisoneNo drug interventionstreatmentNot Availablecompleted
NCT06544343
Integration of Remote Monitoring in the Management of Chronic Immunosuppressive TherapyNo drug interventionstreatmentNot Availablerecruiting